doi: 10.1186/s12933-018-0800-2
Monitoring requirements include assessment for signs of pancreatitis (persistent severe abdominal pain, often radiating to the back, with or without vomiting) and gallbladder disease (right upper quadrant pain, nausea, vomiting), both of which have been reported with GLP-1 receptor agonists
Weight Loss Results: If your goal is weight loss with Semaglutide (including under brand names like Ozempic and Wegovy), you may begin to see visible changes within a few weeks
Though some people associate Ozempic with weight loss due to its active ingredient, it is exclusively approved for diabetes management
The next big surprise came as some female patients began to report the drugs were improving their fertility odds
Swirl gently do not shake